High CYCLON expression was significantly associated to high MYC expression and was correlated with inferior clinical outcome in R-CHOP but not CHOP-treated DLBCL patients, particularly of the GCB-subtype. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.